Pharvaris to Present in Upcoming March Investor

Pharvaris to Present in Upcoming March Investor

ZUG, Switzerland, March 02, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor......

menu
menu